Ann Arbor Stage IV Grade 3 Follicular Lymphoma Active Not Recruiting Phase 1 Trials for Ibrutinib (DB09053)

IndicationStatusPhase
DBCOND0093323 (Ann Arbor Stage IV Grade 3 Follicular Lymphoma)Active Not Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01829568Rituximab, Lenalidomide, and Ibrutinib in Treating Patients With Previously Untreated Stage II-IV Follicular LymphomaTreatment